Tuesday, April 11, 2023 by: Mike Adams Tags: badhealth, badmedicine, cancer, cancer causes, COVID, gain-of-function, immune system, jabs, mRNA, tumors, vaccines This article may contain statements that reflect the opinion…
Tag: SARSCoV2
Organoids reveal how SARS-CoV-2 damages brain cells — and a potential treatment — ScienceDaily
Using human brain organoids, an international team of researchers, led by scientists at University of California San Diego School of Medicine and Sanford Consortium, has shown how the SARS-CoV-2 virus…
Moderna patented a 19-nucleotide sequence in 2013 that matches the most infectious sequence of SARS-CoV-2 – NaturalNews.com
(Natural News) In the quest to uncover the origins for SARS-CoV-2, scientists did not have to look very far. For years, the National Institutes of Health, in cooperation with EcoHealth…
Forecasting COVID-19 surges based on SARS-CoV-2 mutation surveillance
In a recent study posted to the bioRxiv* preprint server, researchers predicted surges in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections based on alterations in SARS-CoV-2 mutations. Study: Future COVID19…
Smoking and the risk of contracting SARS-CoV-2 and COVID-19
Smoking increases the risk of respiratory infections, such as colds, flu, pneumonia, and tuberculosis. Smoking may also contribute to coronavirus disease 2019 (COVID-19) complications. Study: Tobacco product use and the risks…
Humans and chiropterans vs. SARS-CoV-2 infection — ScienceDaily
Bat cells have specific molecular barriers to deal with SARS-CoV-2 replication, according to a study published in the Journal of Virology — a publication of the American Society of Microbiology…
Targeting a human protein to squash SARS-CoV-2 and other viruses — ScienceDaily
More than two years into the COVID-19 pandemic, people are realizing that the “new normal” will probably involve learning to co-exist with SARS-CoV-2. Some treatments are available, but with new…
Model predicts effectiveness of COVID-19 vaccines against circulating SARS-CoV-2 variants
In a recent study published in the journal Nature Medicine, researchers assessed the coronavirus disease 2019 (COVID-19) vaccine effectiveness (VE) against symptomatic infections with severe acute respiratory syndrome coronavirus 2…
Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022
On April 26, 2022, this report was posted online as an MMWR Early Release. In December 2021, the B.1.1.529 (Omicron) variant of SARS-CoV-2, the virus that causes COVID-19, became predominant…